Zimmer Biomet Holdings, Inc. (ZBH) Q3 2017 Earnings Results

Zimmer Biomet Misses on EPS, Stock Down 5.37%

Zimmer Biomet's earnings report showed a slight miss on EPS, which contributed to a 5.37% drop in stock price. The lack of revenue data and guidance may raise concerns among investors about future performance. Management's defensive tone suggests they are aware of market challenges and are preparing to adapt their strategies accordingly.

The print

Key numbers

Actual vs. consensus

Metric	Actual	Expected	Surprise
EPS	$1.72	N/A	-1.22%
Revenue	N/A	N/A	N/A

Management

Management commentary

Tone: Defensive

Management expressed concerns about market conditions impacting performance. They are focused on adapting strategies to navigate these challenges.

Management highlighted ongoing challenges in the market.

They emphasized the need for strategic adjustments moving forward.

Zimmer Biomet Misses on EPS, Stock Down 5.37%

Key numbers

Management commentary

Zimmer Biomet Holdings, Inc.

More earnings this week

Zimmer Biomet Misses on EPS, Stock Down 5.37%

Key numbers

Management commentary